Laura I. Escobar , Carlos Daniel Quezada Suaste , Carolina Salvador , Daniel León Aparicio , Carolina Monserrath Melchor-Meneses , Jorge Bravo-Martínez , Víctor de la Rosa , Zinaeli López-González , Federico del Río-Portilla
{"title":"重组松香毒素κ-SrXIA的Kv1钾通道阻滞及核磁共振结构","authors":"Laura I. Escobar , Carlos Daniel Quezada Suaste , Carolina Salvador , Daniel León Aparicio , Carolina Monserrath Melchor-Meneses , Jorge Bravo-Martínez , Víctor de la Rosa , Zinaeli López-González , Federico del Río-Portilla","doi":"10.1016/j.toxicon.2025.108384","DOIUrl":null,"url":null,"abstract":"<div><div>The biologically active components of <em>Conus</em> venoms are mainly small peptides with disulfide-bonded structures. Some conotoxins contain post-translational modifications as an evolutionary strategy to enhance their potency and selectivity towards ion channels and receptors. Few conotoxins are known to target mammalian Kv1 channels. κ-SrXIA from the venom of <em>Conus spurius</em> inhibits the voltage-gated potassium Kv1.2 and Kv1.6 channels through a basic ring of Arg. The 32 amino acid κ-SrXIA has eight Cys residues arranged in the pattern that defines the I-superfamily with four disulfide bridges, two gamma-carboxy-glutamates (Gla), and a Pro-amidated C-terminus (X). In this study, we obtained and determined the biological activity and NMR structure of recombinant κ-SrXIA without Gla and X. The conotoxin cDNA was expressed in <em>E. coli</em> CD41 and purified by GST-affinity chromatography and RP-HPLC. Pharmacological assays were performed by two-electrode voltage-clamp recordings in <em>Xenopus laevis</em> oocytes expressing recombinant Kv1.1, Kv1.2, Kv1.3, Kv1.4 and Kv1.6 channels. Except for Kv1.3, κ-Sr-XIA irreversibly blocked Kv1 channels displaying a lower affinity and a slower inhibition kinetics than native conotoxin. Even when κ-SrXIA displayed a high structural similarity to GXIA from the I<sub>3</sub>-superfamily, the resultant disulfide connectivity forming an ICK+1 motif showed two antiparallel β-strands as ι-RXIA from the I<sub>1</sub>-superfamily. This study represents the first 3D NMR structure for a member of the I<sub>2</sub>-superfamily.</div></div>","PeriodicalId":23289,"journal":{"name":"Toxicon","volume":"262 ","pages":"Article 108384"},"PeriodicalIF":2.6000,"publicationDate":"2025-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Block of Kv1 potassium channels and NMR structure of recombinant conotoxin κ-SrXIA\",\"authors\":\"Laura I. Escobar , Carlos Daniel Quezada Suaste , Carolina Salvador , Daniel León Aparicio , Carolina Monserrath Melchor-Meneses , Jorge Bravo-Martínez , Víctor de la Rosa , Zinaeli López-González , Federico del Río-Portilla\",\"doi\":\"10.1016/j.toxicon.2025.108384\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The biologically active components of <em>Conus</em> venoms are mainly small peptides with disulfide-bonded structures. Some conotoxins contain post-translational modifications as an evolutionary strategy to enhance their potency and selectivity towards ion channels and receptors. Few conotoxins are known to target mammalian Kv1 channels. κ-SrXIA from the venom of <em>Conus spurius</em> inhibits the voltage-gated potassium Kv1.2 and Kv1.6 channels through a basic ring of Arg. The 32 amino acid κ-SrXIA has eight Cys residues arranged in the pattern that defines the I-superfamily with four disulfide bridges, two gamma-carboxy-glutamates (Gla), and a Pro-amidated C-terminus (X). In this study, we obtained and determined the biological activity and NMR structure of recombinant κ-SrXIA without Gla and X. The conotoxin cDNA was expressed in <em>E. coli</em> CD41 and purified by GST-affinity chromatography and RP-HPLC. Pharmacological assays were performed by two-electrode voltage-clamp recordings in <em>Xenopus laevis</em> oocytes expressing recombinant Kv1.1, Kv1.2, Kv1.3, Kv1.4 and Kv1.6 channels. Except for Kv1.3, κ-Sr-XIA irreversibly blocked Kv1 channels displaying a lower affinity and a slower inhibition kinetics than native conotoxin. Even when κ-SrXIA displayed a high structural similarity to GXIA from the I<sub>3</sub>-superfamily, the resultant disulfide connectivity forming an ICK+1 motif showed two antiparallel β-strands as ι-RXIA from the I<sub>1</sub>-superfamily. This study represents the first 3D NMR structure for a member of the I<sub>2</sub>-superfamily.</div></div>\",\"PeriodicalId\":23289,\"journal\":{\"name\":\"Toxicon\",\"volume\":\"262 \",\"pages\":\"Article 108384\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-05-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Toxicon\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0041010125001588\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Toxicon","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0041010125001588","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Block of Kv1 potassium channels and NMR structure of recombinant conotoxin κ-SrXIA
The biologically active components of Conus venoms are mainly small peptides with disulfide-bonded structures. Some conotoxins contain post-translational modifications as an evolutionary strategy to enhance their potency and selectivity towards ion channels and receptors. Few conotoxins are known to target mammalian Kv1 channels. κ-SrXIA from the venom of Conus spurius inhibits the voltage-gated potassium Kv1.2 and Kv1.6 channels through a basic ring of Arg. The 32 amino acid κ-SrXIA has eight Cys residues arranged in the pattern that defines the I-superfamily with four disulfide bridges, two gamma-carboxy-glutamates (Gla), and a Pro-amidated C-terminus (X). In this study, we obtained and determined the biological activity and NMR structure of recombinant κ-SrXIA without Gla and X. The conotoxin cDNA was expressed in E. coli CD41 and purified by GST-affinity chromatography and RP-HPLC. Pharmacological assays were performed by two-electrode voltage-clamp recordings in Xenopus laevis oocytes expressing recombinant Kv1.1, Kv1.2, Kv1.3, Kv1.4 and Kv1.6 channels. Except for Kv1.3, κ-Sr-XIA irreversibly blocked Kv1 channels displaying a lower affinity and a slower inhibition kinetics than native conotoxin. Even when κ-SrXIA displayed a high structural similarity to GXIA from the I3-superfamily, the resultant disulfide connectivity forming an ICK+1 motif showed two antiparallel β-strands as ι-RXIA from the I1-superfamily. This study represents the first 3D NMR structure for a member of the I2-superfamily.
期刊介绍:
Toxicon has an open access mirror Toxicon: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review. An introductory offer Toxicon: X - full waiver of the Open Access fee.
Toxicon''s "aims and scope" are to publish:
-articles containing the results of original research on problems related to toxins derived from animals, plants and microorganisms
-papers on novel findings related to the chemical, pharmacological, toxicological, and immunological properties of natural toxins
-molecular biological studies of toxins and other genes from poisonous and venomous organisms that advance understanding of the role or function of toxins
-clinical observations on poisoning and envenoming where a new therapeutic principle has been proposed or a decidedly superior clinical result has been obtained.
-material on the use of toxins as tools in studying biological processes and material on subjects related to venom and antivenom problems.
-articles on the translational application of toxins, for example as drugs and insecticides
-epidemiological studies on envenoming or poisoning, so long as they highlight a previously unrecognised medical problem or provide insight into the prevention or medical treatment of envenoming or poisoning. Retrospective surveys of hospital records, especially those lacking species identification, will not be considered for publication. Properly designed prospective community-based surveys are strongly encouraged.
-articles describing well-known activities of venoms, such as antibacterial, anticancer, and analgesic activities of arachnid venoms, without any attempt to define the mechanism of action or purify the active component, will not be considered for publication in Toxicon.
-review articles on problems related to toxinology.
To encourage the exchange of ideas, sections of the journal may be devoted to Short Communications, Letters to the Editor and activities of the affiliated societies.